José T. Ortiz-Pérez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
José T. Ortiz-Pérez has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Xavier Bosch
Hospital Clínic and IDIBAPS (Institut d'Investigació Agustí Pi i Sunyer), Barcelona, Catalonia, Spain
4 shared publications - Daniel C. Lee
Department of Radiology, Northwestern University Feinberg School of Medicine, 737 N Michigan Ave, Ste 1600, Chicago, IL 60611
2 shared publications - Edwin Wu
Department of Medicine, Division of Cardiology, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
2 shared publications Marta Sitges
2 shared publicationsRosario J Perea
Institut d'investigacions Biomèdiques August Pi i Sunyer, IDIBAPS, University of Barcelona, Spain
2 shared publicationsRosario J. Perea
2 shared publications
Latest Publications
- 9 November 2017
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 8 (8) , 708-716
Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction
Serum soluble AXL (sAXL) and its ligand, Growth Arrest-Specific 6 protein (GAS6), intervene in tissue repair processes. AXL is increased in end-stage heart failure, but the role of GAS6 and sAXL in ST-segment elevation myocardial infarction (STEMI) is unknown. To study the association of sAXL and GAS6 acutely and six months following STEMI with heart failure and left ventricular remodelling. GAS6 and sAXL were measured by enzyme-linked immunosorbent assay at one day, seven days and six months in 227 STEMI patients and 20 controls. Contrast-enhanced magnetic resonance was performed during admission and at six months to measure infarct size and left ventricular function. GAS6, but not sAXL, levels during admission were significantly lower in STEMI than in controls. AXL increased progressively over time (p1) had higher values of sAXL at day 1 (48.9±11.9 vs. 44.0±10.7 ng/ml; pvs. 55.9±13.7 ng/ml; p<0.05). GAS6 levels were not different among subjects with heart failure or left ventricular remodelling. By multivariate analysis including infarct size, Killip class and sAXL at seven days, only the last two were independent predictors of left ventricular remodelling (odds ratio 2.24 (95% confidence interval: 1.08–4.63) and odds ratio 1.04 (95% confidence interval: 1.00–1.08) respectively). sAXL levels increased following STEMI. Patients with heart failure and left ventricular remodelling have higher sAXL levels acutely and at six month follow-up. These findings suggest a potential role of the GAS6–AXL system in the pathophysiology of left ventricular remodelling following STEMI.
- 9 November 2017
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 8 (8) , 708-716
Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction
Serum soluble AXL (sAXL) and its ligand, Growth Arrest-Specific 6 protein (GAS6), intervene in tissue repair processes. AXL is increased in end-stage heart failure, but the role of GAS6 and sAXL in ST-segment elevation myocardial infarction (STEMI) is unknown. To study the association of sAXL and GAS6 acutely and six months following STEMI with heart failure and left ventricular remodelling. GAS6 and sAXL were measured by enzyme-linked immunosorbent assay at one day, seven days and six months in 227 STEMI patients and 20 controls. Contrast-enhanced magnetic resonance was performed during admission and at six months to measure infarct size and left ventricular function. GAS6, but not sAXL, levels during admission were significantly lower in STEMI than in controls. AXL increased progressively over time (p1) had higher values of sAXL at day 1 (48.9±11.9 vs. 44.0±10.7 ng/ml; pvs. 55.9±13.7 ng/ml; p<0.05). GAS6 levels were not different among subjects with heart failure or left ventricular remodelling. By multivariate analysis including infarct size, Killip class and sAXL at seven days, only the last two were independent predictors of left ventricular remodelling (odds ratio 2.24 (95% confidence interval: 1.08–4.63) and odds ratio 1.04 (95% confidence interval: 1.00–1.08) respectively). sAXL levels increased following STEMI. Patients with heart failure and left ventricular remodelling have higher sAXL levels acutely and at six month follow-up. These findings suggest a potential role of the GAS6–AXL system in the pathophysiology of left ventricular remodelling following STEMI.
- Open Access
- 1 January 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 18 (1) , 78-9
Benefits of chronic total coronary occlusion percutaneous intervention in patients with heart failure and reduced ejection fraction: insights from a cardiovascular magnetic resonance study
- 1 January 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 18 (1) , 78-9
Open AccessBenefits of chronic total coronary occlusion percutaneous intervention in patients with heart failure and reduced ejection fraction: insights from a cardiovascular magnetic resonance study
- 1 February 2015
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 68 (2) , 165-166
Comentarios a la evaluación del dolor torácico agudo mediante ecocardiografía de ejercicio y tomografía computarizada multidetectores. Respuesta
- 1 February 2015
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 68 (2) , 165-166
Comentarios a la evaluación del dolor torácico agudo mediante ecocardiografía de ejercicio y tomografía computarizada multidetectores. Respuesta
- 1 February 2015
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 68 (2) , 165-6
Comments on exercise echocardiography and multidetector computed tomography for the evaluation of acute chest pain. Response.
- 1 February 2015
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 68 (2) , 165-6
Comments on exercise echocardiography and multidetector computed tomography for the evaluation of acute chest pain. Response.
- 1 January 2015
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 68 (1) , 17-24
Exercise Echocardiography and Multidetector Computed Tomography for the Evaluation of Acute Chest Pain
- 1 January 2015
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 68 (1) , 17-24
Exercise Echocardiography and Multidetector Computed Tomography for the Evaluation of Acute Chest Pain
- Open Access
- 22 April 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e61695
Role of Circulating Angiotensin Converting Enzyme 2 in Left Ventricular Remodeling following Myocardial Infarction: A Prospective Controlled Study
Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1–7), a cardioprotective peptide. Serum soluble ACE2 (sACE2) activity is raised in chronic heart failure, suggesting a compensatory role in left ventricular dysfunction . Our aim was to study the relationship between sACE2 activity, infarct size, left ventricular systolic function and remodeling following ST-elevation myocardial infarction (STEMI). A contrast-enhanced cardiac magnetic resonance study was performed acutely in 95 patients with first STEMI and repeated at 6 months to measure LV end-diastolic volume index, ejection fraction and infarct size. Baseline sACE2 activities, measured by fluorescent enzymatic assay 24 to 48 hours and at 7 days from admission, were compared to that obtained in 22 matched controls. Patients showed higher sACE2 at baseline than controls (104.4 [87.4–134.8] vs 74.9 [62.8–87.5] RFU/µl/hr, p<0.001). At seven days, sACE2 activity significantly increased from baseline (115.5 [92.9–168.6] RFU/µl/hr, p<0.01). An inverse correlation between sACE2 activity with acute and follow-up ejection fraction was observed (r = −0.519, p<0.001; r = −0.453, p = 0.001, respectively). Additionally, sACE2 directly correlated with infarct size (r = 0.373, p<0.001). Both, infarct size (β = −0.470 [95%CI:−0.691:−0.248], p<0.001) and sACE2 at 7 days (β = −0.025 [95%CI:−0.048:−0.002], p = 0.030) were independent predictors of follow-up ejection fraction. Patients with sACE2 in the upper tertile had a 4.4 fold increase in the incidence of adverse left ventricular remodeling (95% confidence interval: 1.3 to 15.2, p = 0.027). In conclusion, serum sACE2 activity rises in relation to infarct size, left ventricular systolic dysfunction and is associated with the occurrence of left ventricular remodeling.
- 22 April 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e61695
Open AccessRole of Circulating Angiotensin Converting Enzyme 2 in Left Ventricular Remodeling following Myocardial Infarction: A Prospective Controlled Study
Angiotensin-converting enzyme 2 (ACE2) cleaves Angiotensin-II to Angiotensin-(1–7), a cardioprotective peptide. Serum soluble ACE2 (sACE2) activity is raised in chronic heart failure, suggesting a compensatory role in left ventricular dysfunction . Our aim was to study the relationship between sACE2 activity, infarct size, left ventricular systolic function and remodeling following ST-elevation myocardial infarction (STEMI). A contrast-enhanced cardiac magnetic resonance study was performed acutely in 95 patients with first STEMI and repeated at 6 months to measure LV end-diastolic volume index, ejection fraction and infarct size. Baseline sACE2 activities, measured by fluorescent enzymatic assay 24 to 48 hours and at 7 days from admission, were compared to that obtained in 22 matched controls. Patients showed higher sACE2 at baseline than controls (104.4 [87.4–134.8] vs 74.9 [62.8–87.5] RFU/µl/hr, p<0.001). At seven days, sACE2 activity significantly increased from baseline (115.5 [92.9–168.6] RFU/µl/hr, p<0.01). An inverse correlation between sACE2 activity with acute and follow-up ejection fraction was observed (r = −0.519, p<0.001; r = −0.453, p = 0.001, respectively). Additionally, sACE2 directly correlated with infarct size (r = 0.373, p<0.001). Both, infarct size (β = −0.470 [95%CI:−0.691:−0.248], p<0.001) and sACE2 at 7 days (β = −0.025 [95%CI:−0.048:−0.002], p = 0.030) were independent predictors of follow-up ejection fraction. Patients with sACE2 in the upper tertile had a 4.4 fold increase in the incidence of adverse left ventricular remodeling (95% confidence interval: 1.3 to 15.2, p = 0.027). In conclusion, serum sACE2 activity rises in relation to infarct size, left ventricular systolic dysfunction and is associated with the occurrence of left ventricular remodeling.
- Open Access
- 1 January 2012
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 14 (1) , 62
Infarct healing is a dynamic process following acute myocardial infarction
- 1 January 2012
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 14 (1) , 62
Open AccessInfarct healing is a dynamic process following acute myocardial infarction
- 1 November 2010
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 63 (11) , 1386-1387
Miocarditis asociada a la gripe A pandémica (H1N1)
- 1 November 2010
- Published by Elsevier in Revista Espanola de Cardiologia
- Vol. 63 (11) , 1386-1387
Miocarditis asociada a la gripe A pandémica (H1N1)
- 1 October 2010
- Published by Elsevier in The American Journal of Cardiology
- Vol. 106 (7) , 924-930
Angiographic and Magnetic Resonance Imaging Evaluation of In-Hospital Delay in Primary Percutaneous Intervention Delivery on Myocardial Salvage
- 1 October 2010
- Published by Elsevier in The American Journal of Cardiology
- Vol. 106 (7) , 924-930
Angiographic and Magnetic Resonance Imaging Evaluation of In-Hospital Delay in Primary Percutaneous Intervention Delivery on Myocardial Salvage